RE:RE:RE:RE:MIXED COMMENTSleSpeculateur wrote: No Nolo, it doesn't asnwer my question. My concern is not about how they will process the sample, my doubt is about how they will sell they Cancer Screening Test a success in other country when they are not able in the USA.
Then you need to write your 'fundamental questions' better because you clearly stated: '
how it will achive the goal in other country, starting from nothing, no lab, no staff.' And how do you know that they are not able to sell Colonsentry in the USA? Did Tripp sent you the Q2 numbers in advance yesterday? I'm not talking about Q1. I'm talking about Q2, what's happening right now as you read this. If they are 'not able to sell', as you say, that means there is no progress made. I'm curious to see what info you have on this since you seem pretty sure of what you're saying. Can you share the data with us, please? That would be awesome of you.